Overall response to first-line tyrosine kinase inhibitor and second-line chemotherapy is predictive of survival outcome in epidermal growth factor receptor-mutated adenocarcinoma.

Kuo, Scott Chih-Hsi; Hsu, Ping-Chih; Chen, Chih-Hung; Yu, Chih-Teng; Wang, Chih-Liang; Chung, Fu-Tsai; Lin, Shu-Min; Lo, Yu-Lun; Chen, Tse-Ching; Liu, Chien-Ying; Yang, Cheng-Ta

Kuo, Scott Chih-Hsi; Hsu, Ping-Chih; Chen, Chih-Hung; Yu, Chih-Teng; Wang, Chih-Liang; Chung, Fu-Tsai; Lin, Shu-Min; Lo, Yu-Lun; Chen, Tse-Ching; Liu, Chien-Ying; Yang, Cheng-Ta.

Chemotherapy ; 60(3): 201-10, 2014.

Article in En | MEDLINE | ID: mdl-25871639

Subject(s)

Adenocarcinoma/drug therapy; Adenocarcinoma/mortality; ErbB Receptors/genetics; Lung Neoplasms/drug therapy; Lung Neoplasms/mortality; Protein Kinase Inhibitors/therapeutic use; Protein-Tyrosine Kinases/antagonists & inhibitors; Adenocarcinoma/genetics; Adenocarcinoma of Lung; Antineoplastic Agents/therapeutic use; Disease-Free Survival; Exons/genetics; Female; Humans; Lung Neoplasms/genetics; Male; Middle Aged; Mutation/genetics; Retrospective Studies; Sequence Deletion/genetics

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Protein-Tyrosine Kinases / Adenocarcinoma / Protein Kinase Inhibitors / ErbB Receptors / Lung Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male / Middle aged Language: En Year: 2014 Type: Article

Search on Google

XML

PubMed Links